Related Experiment Video
Updated: May 24, 2025
Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Evaluating Poison Control Center Telemedicine Support for Health Care Facilities in Managing Overdose and Suicide
Priyanka Vakkalanka1,2, Eliezer Santos-Léon1,3, Zachary Case1
1Department of Emergency Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.
Abstract:
Background: We aimed to assess differences in the impact of the COVID-19 public health emergency (PHE) on urban and rural health care facility (HCF) management of intentional overdoses and self-harm using telemedicine consultation from poison control centers (PCCs). Methods: We utilized a mixed-methods, explanatory study design of poison centers in the United States. The primary exposures were geography (urban vs. rural HCFs) and time (the pre-COVID-19 PHE [January 1, 2018-March 10, 2020] vs. COVID-19 PHE [March 11, 2020-December 31, 2022]). The primary outcomes were patient disposition: admission to critical care unit (CCU); non-CCU; or psychiatric facility. We measured these associations using a multinomial regression, adjusting for demographic and clinical factors. We interviewed PCC staff to gain insight about perspectives of PCC staff in managing intentional overdoses. Results: Of the 1,416,809 intentional overdoses identified, 1,313,704 (93%) were included in our analysis. Compared with urban HCFs in the pre-COVID-19 era, CCU admissions were greater among rural HCFs (adjusted odds ratio [aOR]: 1.12; 95% confidence interval [CI]: 1.10-1.14); however, they were lower in the COVID-19 PHE era within rural (aOR: 0.72; 95% CI: 0.71-0.73) and urban HCFs (aOR: 0.74; 95% CI: 0.73-0.75). Trends were similar in non-CCU and psychiatric admissions. We identified four themes: challenges of admitting overdose cases; changes in calls related to COVID-19 and intentional overdoses; changes in technology, staffing, and operations to adapt to the COVID-19 PHE; and changes in communications for telemedicine. Conclusions: The COVID-19 PHE introduced challenges for urban and rural HCFs in treating mental health and overdoses. PCCs are a vital source of telemedicine support available to both urban and rural clinical providers to ease the existing health care burden.
Related Concept Videos
01:14Prevention of Further Absorption of Poison
01:26Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
01:19Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:26Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
01:30Specialized Care Centers and Settings-I
Daycare centers
They provide several functions. Some facilities care for healthy newborns and children whose parents work, while others are medically focused and care for...
01:17Antidotes
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...